Adverum Biotechnologies has filed a notice of an exempt offering of securities to raise $127,800,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Adverum Biotechnologies is raising up to $127,800,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Linda Rubinstein played a…